Klaria Pharma Holding AB (publ.) (STO:KLAR)
Sweden
· Delayed Price · Currency is SEK 0.897
-0.015 (-1.64%)
Apr 29, 2026, 11:30 AM CET
STO:KLAR Revenue
In the year 2025, Klaria Pharma Holding AB (publ.) had annual revenue of 8.99M SEK with 299.69% growth.
Revenue
8.99M
Revenue Growth
+299.69%
P/S Ratio
24.97
Revenue / Employee
2.25M
Employees
4
Market Cap
224.33M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.99M | 6.74M | 299.69% |
| Dec 31, 2024 | 2.25M | -6.21M | -73.41% |
| Dec 31, 2023 | 8.45M | 2.59M | 44.07% |
| Dec 31, 2022 | 5.87M | -244.00K | -3.99% |
| Dec 31, 2021 | 6.11M | -1.11M | -15.35% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cinclus Pharma Holding AB | 57.47M |
| Moberg Pharma AB | 13.54M |
| Vivesto AB | -131.00K |
| Nanexa AB | 55.94M |
| Enzymatica AB | 53.90M |
| Orexo AB | 26.00M |
| Dicot Pharma AB | 200.00K |
| Newbury Pharmaceuticals AB | 32.78M |